Patrick Rosengren

Mr. Patrick Rosengren

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
PRPatrick Rosengren
Patrick Rosengren
LJLiam Johnston
Liam Johnston
IIIbrahim Ismail
Ibrahim Ismail
SSSimon Smith
Simon Smith
JHJosh Hanson
Josh Hanson
This scoping review of original literature published before 1 March 2025 examined the demographic and simple clinical and laboratory findings associated with the development of severe leptospirosis. The definition of severe leptospirosis varied in different studies, but for the purposes of this review it included death or patients with a more complicated clinical course. There were 35 articles that satisfied the review’s inclusion criteria. Increasing age was associated with severe disease in 7 studies. Abnormal respiratory examination findings (18 studies), hypotension (11 studies), oliguria (8 studies), jaundice (7 studies) and altered mental status (4 studies) also helped identify high-risk patients. Abnormal laboratory tests—specifically the complete blood count (17 studies), measures of renal function (16 studies) and liver function (14 studies)—were also associated with severe disease. There was geographical heterogeneity in the clinical phenotype of severe disease, but the presence of hypotension, respiratory or renal involvement had prognostic utility in all regions. Simple bedside findings and basic laboratory tests can provide valuable clinical information in patients with leptospirosis. Integration of these indices into early risk stratification tools may facilitate recognition of the high-risk patient and expedite escalation of care in resource-limited settings where most cases of life-threatening leptospirosis are seen.

28 June 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
HSHayley Stratton
Hayley Stratton
PRPatrick Rosengren
Patrick Rosengren
TKToni Kinneally
Toni Kinneally
LPLaura Prideaux
Laura Prideaux
SSSimon Smith
Simon Smith
JHJosh Hanson
Josh Hanson
The case-fatality rate of severe leptospirosis can exceed 50%. This retrospective cohort study examined 111 individuals with laboratory-confirmed leptospirosis admitted to Cairns Hospital, a referral hospital in tropical Australia, between January 2015 and June 2024. We examined the patients’ demographic, clinical, laboratory and imaging findings at presentation and then correlated them with the patients’ subsequent clinical course. Severe disease was defined as the presence of pulmonary haemorrhage or a requirement for intensive care unit (ICU) admission. The patients’ median (interquartile range) age was 38 (24–55) years; 85/111 (77%) were transferred from another health facility. Only 13/111 (12%) had any comorbidities. There were 63/111 (57%) with severe disease, including 56/111 (50%) requiring ICU admission. Overall, 56/111 (50%) required vasopressor support, 18/111 (16%) needed renal replacement therapy, 14/111 (13%) required mechanical ventilation and 2/111 (2%) needed extracorporeal membrane oxygenation. Older age—but not comorbidity—was associated with the presence of severe disease. Hypotension, respiratory involvement, renal involvement and myocardial injury—but not liver involvement—frequently heralded a requirement for ICU care. Every patient in the cohort survived to hospital discharge. Leptospirosis can cause multi-organ failure in otherwise well young people in tropical Australia; however, patient outcomes are usually excellent in the country’s well-resourced health system.

25 May 2026 in Acta Tropica
Verified
Journal Article
Open access
SHSamuel Hart
Samuel Hart
SSSimon Smith
Simon Smith
BNBen Nash
Ben Nash
HSHayley Stratton
Hayley Stratton
PRPatrick Rosengren
Patrick Rosengren
JHJosh Hanson
Josh Hanson
The case-fatality rate of patients with leptospirosis requiring intensive care unit (ICU) admission in resource-limited settings can exceed 50%. However, the optimal care of critically ill patients with this life-threatening infection is incompletely defined. This retrospective study examined the demographic, clinical, laboratory and imaging findings in consecutive individuals with a laboratory-confirmed diagnosis of leptospirosis admitted to the ICU of an Australian referral hospital between May 2015 and April 2025. The care provided to the patients was correlated with their clinical course. The median (interquartile range, IQR) of the 60 individuals was 43 (26-65) years; 49/60 (82%) had no pre-existing comorbidity. The patients' median (IQR) APACHE-III score was 63 (46-89). Multi-organ dysfunction was common: 48/60 (80%) needed vasopressor support, a lung protective ventilation strategy was employed in the 16/60 (27%) requiring mechanical ventilation and renal replacement therapy was initiated in 12/60 (20%) using standard indications. Two patients received extracorporeal membrane oxygenation. While awaiting a diagnosis of leptospirosis, patients were managed using contemporary principles of sepsis care: all 60 patients received antibiotics, fluid resuscitation was conservative and transfusion of blood products was restrictive. Corticosteroids were provided to 23/60 (38%), but this was usually short course hydrocortisone therapy for blood pressure support. All 60 patients survived to discharge and were alive 90 days later. Leptospirosis can cause life-threatening multi-organ failure in young people without comorbidity. However, in Australia's well-resourced health system, excellent outcomes can be achieved using standard principles of sepsis management before the diagnosis is confirmed.

12 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PRPatrick Rosengren
Patrick Rosengren
LJLiam Johnston
Liam Johnston
IIIbrahim Ismail
Ibrahim Ismail
SSSimon Smith
Simon Smith
JHJosh Hanson
Josh Hanson
This scoping review of original literature published before 1 March 2025 examined the de-mographic, clinical and simple laboratory findings associated with the development of severe leptospirosis. The definition of severe leptospirosis varied in different studies, but for the purposes of this review it included death or patients with a more complicated clinical course. There were 35 articles that satisfied the review’s inclusion criteria. Increasing age was asso-ciated with severe disease in 7 studies. Abnormal respiratory examination findings (18 stud-ies), hypotension (11 studies), oliguria (8 studies), jaundice (7 studies) and altered mental status (4 studies) also helped identify high-risk patients. Abnormal laboratory tests – specifi-cally the complete blood count (17 studies), measures of renal function (16 studies) and liver function (14 studies) – were also associated with severe disease. There was geographical heterogeneity in the clinical phenotype of severe disease, but the presence of hypotension, respiratory or renal involvement had prognostic utility in all regions. Simple bedside findings and basic laboratory tests can provide valuable clinical information in patients with lepto-spirosis. Integration of these indices into early risk stratification tools may facilitate recogni-tion of the high-risk patient and expedite escalation of care in resource-limited settings where most cases of life-threatening leptospirosis are seen.

Verified
Journal Article
Open access
PDF file
ASAdam Sykes
Adam Sykes
SSSimon Smith
Simon Smith
HSHayley Stratton
Hayley Stratton
MSMegan Staples
Megan Staples
PRPatrick Rosengren
Patrick Rosengren
JHJosh Hanson
Josh Hanson
Lung involvement in patients with leptospirosis is associated with a more complicated disease course. However, the demographic and clinical associations of lung involvement are incompletely defined, and its optimal management is uncertain. This retrospective study examined consecutive patients admitted to a referral hospital in tropical Australia, with laboratory-confirmed leptospirosis between January 2015, and June 2024. Lung involvement was defined as new lung parenchymal changes on chest imaging at any point during the patients’ hospitalisation. The demographics, clinical findings and clinical course of the patients with and without lung involvement were compared. The median (interquartile range (IQR)) age of the 109 patients was 39 (24–56) years; 93/109 (85%) were male. Lung involvement was present in 62/109 (57%), 55 (89%) of whom had no documented comorbidities. Patients with lung involvement received antibiotics later in their disease course than those without lung involvement (after a median (IQR) of 5 (4–6) versus 3 (2–5) days of symptoms, p = 0.001). Lung involvement was frequently associated with multi-organ failure: patients with lung involvement were more likely to require intensive care unit admission than patients without lung involvement (41/62 (66%) versus 15/47 (32%), p < 0.001). Overall, 30/109 (28%) satisfied criteria for acute respiratory distress syndrome (ARDS) and 26/109 (24%) developed pulmonary haemorrhage. Patients with lung involvement received cautious fluid resuscitation, vasopressor support and prompt initiation of additional supportive care—including mechanical ventilation, renal replacement therapy and extracorporeal membranous oxygenation—guided by the patients’ physiological parameters and clinical trajectory. All 109 patients in the cohort were alive 90 days after discharge. Life-threatening lung involvement was identified in the majority of individuals in this cohort and occurred in young and otherwise well individuals. However, in Australia’s well-resourced health system excellent outcomes can be achieved using a standard contemporary approach to the management of a patient with undifferentiated infection while a confirmed diagnosis of leptospirosis is awaited.

19 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HSHayley Stratton
Hayley Stratton
PRPatrick Rosengren
Patrick Rosengren
TKToni Kinneally
Toni Kinneally
LPLaura Prideaux
Laura Prideaux
SSSimon Smith
Simon Smith
JHJosh Hanson
Josh Hanson
The case-fatality rate of severe leptospirosis can exceed 50%. This retrospective cohort study examined 111 individuals with laboratory-confirmed leptospirosis admitted to Cairns Hospital, a referral hospital in tropical Australia, between January 2015 and June 2024. We examined the patients’ demographic, clinical, laboratory and imaging findings at presentation and correlated them with disease course. Severe disease was defined as the presence of pulmonary haemorrhage or a requirement for intensive care unit (ICU) admission. The patients’ median (interquartile range) age was 38 (24-55) years; 85/111 (77%) were transferred from another health facility. Only 13/111 (12%) had any comorbidities. There were 63/111 (57%) with severe disease, including 56/111 (50%) requiring ICU admission. Overall, 56/111 (50%) required vasopressor support, 18/111 (16%) required renal replacement therapy, 14/111 (13%) required mechanical ventilation and 2/111 (2%) required extracorporeal membrane oxygenation. Older age – but not comorbidity – was associated with the presence of severe disease. Hypotension, respiratory involvement, renal involvement and myocardial injury – but not liver involvement – frequently heralded a requirement for ICU care. Every patient in the cohort survived to hospital discharge. Leptospirosis can cause multi-organ failure in otherwise well young people in tropical Australia; however, outcomes are usually excellent in the country’s well-resourced health system.